# US 2017/0304214 A1 · Therapeutic electrospun fiber compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0304214 A1
- Document ID: US20170304214A1
- Status: Published application
- Kind: A1
- Application number: 15/498,075
- Filed: 2017-04-26
- Published: 2017-10-26
- Earliest claimed: 2006-02-02
- Assignees: The Johns Hopkins University
- Applicants: The Johns Hopkins University
- Inventors: Ahmet Hoke; Sing Y. Chew; Ruifa Mi; Kam W. Leong
- Web page: https://patentgrep.com/patent/US20170304214A1

## CPC

- A61K 9/70: Web, sheet or filament bases {; Films; Fibres of the matrix type containing drug (hollow drug-filled fibres A61K9/0092)}
- A61B 17/1128: {of nerves}
- A61F 2/00: Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00)
- A61K 31/70: Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047)
- A61K 31/7088: Compounds having three or more nucleosides or nucleotides
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/44: having a macromolecular matrix
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/047: {Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61P 25/00: Drugs for disorders of the nervous system
- E04D 13/076: Devices or arrangements for removing snow, ice or debris from gutters or for preventing accumulation thereof
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00526: {Methods of manufacturing}
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L 2300/23: Carbohydrates
- A61L 2300/252: Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A61L 2300/256: Antibodies, e.g. immunoglobulins, vaccines
- A61L 2300/258: Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
- A61L 2300/414: Growth factors
- A61L 2300/426: Immunomodulating agents, i.e. cytokines, interleukins, interferons
- A61L 2300/604: Biodegradation
- A61L 2430/32: for nerve reconstruction
- D01D 5/0007: {Electro-spinning (non-woven fabrics produced by electro-spinning D04H1/728)}
- D01F 1/10: Other agents for modifying properties
- D10B 2331/041: derived from hydroxy-carboxylic acids, e.g. lactones
- D10B 2331/06: polyethers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- E04D: ROOF COVERINGS; SKY-LIGHTS; GUTTERS; ROOF-WORKING TOOLS (coverings of outer walls by plaster or other porous material E04F13/00)
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01F: CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D10B: INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES

## Abstract

The instant invention provides electrospun fiber compositions comprising one or more polymers and one or more biologically active agents. In specific embodiments, the biologically active agents are nerve growth factors. In certain embodiments, the electrospun fiber compositions comprising one or more biologically active agents are on the surface of a film, or a tube. The tubes comprising the electrospun fiber compositions of the invention can be used, for example, as nerve guide conduits.

## Claims

### Claim 1

An electrospun fiber composition comprising one or more polymers and one or more biological therapeutics; or
an electrospun fiber composition comprising PCLEEP and one or more therapeutically active molecules; or
a cylindrical polymer film comprising an inner surface, an outer surface, and a lumen, wherein an electrospun fiber composition comprising one or more polymers and one or more therapeutically active molecules is present on the inner or outer surface of the cylindrical polymer film.

### Claim 2 (depends on 1)

The electrospun fiber composition of claim 1, wherein the one or more biological therapeutics are selected from the group consisting of a polypeptide, polypeptide fragment, nucleic acid molecule, and carbohydrates.

### Claim 3 (depends on 2)

The electrospun fiber composition of claim 2, wherein the one or more biological therapeutics comprise a polypeptide.

### Claim 4 (depends on 3)

The electrospun fiber composition of claim 3, wherein the polypeptide is a growth factor, chemokine, cytokine, receptor, antibody, scFv, antibody fragment or combinations thereof.

### Claim 5 (depends on 3)

The electrospun fiber composition of claim 3, further comprising an additional polypeptide.

### Claim 6 (depends on 5)

The electrospun fiber composition of claim 5, wherein the additional polypeptide is a filler polypeptide.

### Claim 7 (depends on 6)

The electrospun fiber composition of claim 6, wherein the filler polypeptide is human serum albumin.

### Claim 8 (depends on 1)

The electrospun fiber composition of claim 1, wherein the electrospun fibers are randomly oriented fibers.

### Claim 9 (depends on 1)

The electrospun fiber composition of claim 1, wherein the electrospun fibers are aligned fibers.

### Claim 10 (depends on 1)

The electrospun fiber composition of claim 1, wherein the electrospun fiber is produced by uniaxial electrospinning.

### Claim 11 (depends on 1)

The electrospun fiber composition of claim 1, wherein the electrospun fiber is produced by coaxial electrospinning.

### Claim 12 (depends on 1)

The electrospun fiber composition of claim 1, wherein the electrospun fiber is produced by multiaxial electrospinning.

### Claim 13 (depends on 1)

The electrospun fiber composition of claim 1, wherein the average fiber diameter is between about 10 nm and 10 um.

### Claim 14 (depends on 12)

The electrospun fiber composition of claim 12, wherein the average fiber diameter is between about 100 um and 1 um.

### Claim 15 (depends on 1)

The electrospun fiber composition of claim 1, wherein the one or more polymers comprise a synthetic polymer, a natural polymer, a protein engineered biopolymer or a combination thereof.

### Claim 16 (depends on 15)

The electrospun fiber composition of claim 15, wherein the one or more polymers comprise a polyester or derivative thereof.

### Claim 17 (depends on 16)

The electrospun fiber composition of claim 16, wherein the polyester is a poly(phosphoester) polymer.

### Claim 18 (depends on 16)

The electrospun fiber composition of claim 16, wherein the polyester is poly (ε-caprolactore-co-ethyl ethylene phosphate (PCLEEP).

### Claim at position 19

-61. (canceled)

### Claim 62

A nerve guide conduit comprising a cylindrical polymer film comprising on the interior surface an electrospun fiber composition comprising one or more polymers and one or more therapeutically active molecules that induce nerve growth.

### Claim at position 21

-70. (canceled)

### Claim 71

A polymer film comprising on one or both surfaces an electrospun fiber composition comprising one or more polymers and one or more biologically active molecules.

### Claim at position 23

-97. (canceled)
